5000th patient treated with protons for eye tumours

From the patient's perspective at the treatment station: The proton beam is directed through the hole in the shield onto the tumour in the eye. The brass shield is adjusted to the individual tumour size and protects the surrounding tissue.

From the patient's perspective at the treatment station: The proton beam is directed through the hole in the shield onto the tumour in the eye. The brass shield is adjusted to the individual tumour size and protects the surrounding tissue. © HZB/. S. Kodalle

The treatment centre for eye tumour therapy in Berlin-Wannsee

The treatment centre for eye tumour therapy in Berlin-Wannsee © HZB/ S. Kodalle

For more than 25 years, Charité – Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have been jointly offering proton radiation therapy for eye tumours. The HZB operates a proton accelerator in Berlin-Wannsee for this purpose, while Charité provides medical care for the patients. The 5000th patient was treated at the beginning of August.

The treatment room and proton accelerator are specially adapted to the requirements for optimal and highly precise treatment of tumours inside the eye and are unique in this combination. The largest group of tumours in the eye is the rare and malignant uveal melanoma, which, as the name suggests, develops in the uvea of the eye.

Proton therapy is used as an effective method of fighting tumours, often as an alternative to removing the eye, with the aim of preserving the eye and its function as much as possible. The protons can be directed very precisely at the tumour, sparing the surrounding healthy tissue. Compared to other radiation methods, proton therapy causes less damage to the cornea, lens, retina and optic nerve in many cases.

8 August 2025 was a special day: it was the day on which the 5000th patient completed their eye tumour treatment. This makes the Berlin experts one of the world's leading centres: together, the two institutions (Charité and HZB) have treated 10 percent of all eye tumours treated with protons worldwide. The cooperation with Charité – Universitätsmedizin Berlin also opens up prospects for the further development of proton therapy in order to carry out even more precise and effective treatments in the future – for the benefit of patients.

(sz)

  • Copy link

You might also be interested in

  • Susanne Nies appointed to EU advisory group on Green Deal
    News
    12.11.2025
    Susanne Nies appointed to EU advisory group on Green Deal
    Dr. Susanne Nies heads the Green Deal Ukraina project at HZB, which aims to support the development of a sustainable energy system in Ukraine. The energy expert has now also been appointed to the European Commission's scientific advisory group to comment on regulatory burdens in connection with the net-zero target (DG GROW).

  • The future of corals – what X-rays can tell us
    Interview
    12.11.2025
    The future of corals – what X-rays can tell us
    This summer, it was all over the media. Driven by the climate crisis, the oceans have now also passed a critical point, the absorption of CO2 is making the oceans increasingly acidic. The shells of certain sea snails are already showing the first signs of damage. But also the skeleton structures of coral reefs are deteriorating in more acidic conditions. This is especially concerning given that corals are already suffering from marine heatwaves and pollution, which are leading to bleaching and finally to the death of entire reefs worldwide. But how exactly does ocean acidification affect reef structures?

    Prof. Dr. Tali Mass, a marine biologist from the University of Haifa, Israel, is an expert on stony corals. Together with Prof. Dr. Paul Zaslansky, X-ray imaging expert from Charité Berlin, she investigated at BESSY II the skeleton formation in baby corals, raised under different pH conditions. Antonia Rötger spoke online with the two experts about the results of their recent study and the future of coral reefs.

  • Long-term stability for perovskite solar cells: a big step forward
    Science Highlight
    07.11.2025
    Long-term stability for perovskite solar cells: a big step forward
    Perovskite solar cells are inexpensive to produce and generate a high amount of electric power per surface area. However, they are not yet stable enough, losing efficiency more rapidly than the silicon market standard. Now, an international team led by Prof. Dr. Antonio Abate has dramatically increased their stability by applying a novel coating to the interface between the surface of the perovskite and the top contact layer. This has even boosted efficiency to almost 27%, which represents the state-of-the-art. After 1,200 hours of continuous operation under standard illumination, no decrease in efficiency was observed. The study involved research teams from China, Italy, Switzerland and Germany and has been published in Nature Photonics.